Skip to main content Accessibility help
×
Hostname: page-component-7bb8b95d7b-dtkg6 Total loading time: 0 Render date: 2024-09-12T02:19:11.452Z Has data issue: false hasContentIssue false

49 - Onchocerciasis

from Section 8 - Helminth infections

Published online by Cambridge University Press:  05 March 2013

David Mabey
Affiliation:
London School of Hygiene and Tropical Medicine
Geoffrey Gill
Affiliation:
University of Liverpool
Eldryd Parry
Affiliation:
Tropical Health Education Trust
Martin W. Weber
Affiliation:
World Health Organization, Jakarta
Christopher J. M. Whitty
Affiliation:
London School of Hygiene and Tropical Medicine
Get access

Summary

The problem in Africa

Thirty-seven million people are estimated to have onchocerciasis, 99 per cent of them in sub-Saharan Africa. The disease is endemic in 27 African countries. Approximately 270 000 people are blind and 500 000 have significant visual loss due to onchocerciasis, though these figures are probably under-estimates. About 6 million people suffer from onchocercal skin lesions (Remme, 2004). In affected areas, up to one person in ten may be blind and more than one person in three over the age of 40, leading severely affected communities to abandon their villages. In one Nigerian community, adolescent girls considered onchodermatitis to be their most significant health problem because of its severe social consequences, and people in areas of Eastern Nigeria describe onchodermatitis as ‘Osepuru nwanyi aka na di’ meaning a disease which ‘prevents a girl from getting married’. Farmers with onchocercal skin disease (OSD) had significantly less farmland under cultivation and had a lower value of personal wealth indicators than those without OSD (Oladepo et al., 1997).

Organism, life cycle and vector

Onchocerciasis is spread by a small black fly of the genus Simulium. Subspecies of this fly have rainforest, Sudan and Guinea savannah as their natural habitat. All require fast-flowing, turbulent water for their larvae to develop, hence infection occurs in communities living near breeding sites and the illness has become known as river blindness.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abiose, A, Jones, B, Cousens, S et al. (1993). Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis. Lancet; 341: 130–4.CrossRefGoogle ScholarPubMed
Ali, MM, Baraka, OZ, AbdelRahman, SI et al. (2003). Immune responses directed against microfilariae correlate with severity of clinical onchodermatitis and treatment history. J Infect Dis; 187: 714–17.CrossRefGoogle ScholarPubMed
Allen, JE, Adjei, O, Bain, O et al. (2008). Of mice, cattle and humans: the immunology and treatment of river blindness. PLoS Negl Trop Dis; 2(4): e217. .CrossRefGoogle ScholarPubMed
Ayong, LS, Tume, CB, Wembe, FE et al. (2005). Development and evaluation of an antigen detection dipstick assay for the diagnosis of human onchocerciasis. Trop Med Int Health; 10: 228–33.CrossRefGoogle Scholar
Awadzi, K, Boakye, DA, Edwards, G et al. (2004). An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol; 98: 231–49.CrossRefGoogle ScholarPubMed
Brieger, WR, Awedoba, AK, Eneanya, CI et al. (1998). The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial. Trop Med Int Hlth; 3: 951–61.CrossRefGoogle ScholarPubMed
Chippaux, JP, Boussinesq, M, Fobi, G et al. (1999). Effect of repeated ivermectin treatments on ocular onchocerciasis: evaluation after six to eight doses. Ophth Epidemiol; 6: 229–46.CrossRefGoogle ScholarPubMed
Diawara, L, Traoré, MO, Badji, A et al. (2009). Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Neg Trop Dis; 3(7): e497, .CrossRefGoogle ScholarPubMed
Hoerauf, A (2008). Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis. Curr Opin Infect Dis 21: 673–681. .CrossRefGoogle ScholarPubMed
Homeida, M, Braide, E, Elhassan, E et al. (2002). APOC's strategy of community-directed treatment with ivermectin (CDTI) and its potential for providing additional health services to the poorest populations. Ann Trop Med Parasitol; 96: S93–104.CrossRefGoogle ScholarPubMed
Hougard, JM, Alley, ES, Yaméogo, L et al. (2001). Eliminating onchocerciasis after 14 years of vector control: a proved strategy. J Infect Dis; 184: 497–503.CrossRefGoogle ScholarPubMed
Kisinza, WN, Kisoka, WJ, Mutalemwa, PP et al. (2008). Community directed interventions for malaria, tuberculosis and vitamin A in onchocerciasis endemic districts of Tanzania. Tanzan J Hlth Res; 10: 232–9.Google ScholarPubMed
Little, MP, Breitling, LP, Basáňez, M-G et al. (2004). Association between microfilarial load and excess mortality in onchocerciasis: an epidemiological study. Lancet; 363: 1514–21.CrossRefGoogle ScholarPubMed
Makunde, WH, Salum, FM, Massaga, JJ, Alilio, MS (2000). Clinical and parasitological aspects of itching caused by onchocerciasis in Morogoro. Tanzania. Ann Trop Med Parasitol; 94: 793–9.CrossRefGoogle ScholarPubMed
Murdoch, ME (1992). The skin and the immune response in onchocerciasis. Trop Doct; 22: S44–55.CrossRefGoogle ScholarPubMed
Murdoch, ME (2008). Skin signs of onchocerciasis. Commun Dermatol; 5: 16–20.Google Scholar
Murdoch, ME, Hay, RJ, Mackenzie, CD et al. (1993). A clinical classification and grading system of the cutaneous changes in onchocerciasis. Br J Dermatol; 129: 260–9.CrossRefGoogle ScholarPubMed
Murdoch, ME, Abiose, A, Garate, T et al. (1996). Human onchocerciasis in Nigeria: isotypic responses and antigen recognition in individuals with defined cutaneous pathology. Am J Trop Med Hyg; 54: 600–12.CrossRefGoogle ScholarPubMed
Murdoch, ME, Asuzu, MC, Hagan, M et al. (2002). Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa. Ann Trop Med Parasitol; 96: 283–96.CrossRefGoogle ScholarPubMed
Mweya, CN, Kalinga, AK, Kabula, B et al. (2007). Onchocerciasis situation in the Tukuyu focus of southwest Tanzania after ten years of ivermectin mass treatment. Tanz Hlth Res Bull; 9: 174–9.Google ScholarPubMed
Oladepo, O, Brieger, WR, Otusanya, S, Kale, OO, Offiong, S, Titiloye, M (1997). Farm land size and onchocerciasis status of peasant farmer in south-western Nigeria. Trop Med Int Hlth; 2: 334–40.CrossRefGoogle ScholarPubMed
Ottesen, E.A (1995). Immune responsiveness and the pathogenesis of human onchocerciasis. J Infect Dis; 171: 659–71.CrossRefGoogle ScholarPubMed
Ovuga, EBL, Okello, DO, Ogwal-Okeng, JW et al. (1995). Social and psychological aspects of onchocercal skin disease in Nebbi District, Uganda. E Afr Med J; 72: 449–53.Google ScholarPubMed
Ozoh, GA, Boussinesq, M, Bissek, A-CZ-K et al. (2007). Evaluation of the diethylcarbamazine patch to evaluate onchocerciasis endemicity in Central Africa. Trop Med Int Hlth; 12: 123–9.Google ScholarPubMed
Ozoh, GA, Murdoch, ME, Bissek, A-C et al. (2011). The African Programme for Onchocerciasis Control: impact on onchocercal skin disease. Trop Med Int Health; 16: 875–83.CrossRefGoogle ScholarPubMed
Pion, SDS, Kaiser, C, Boutros-Toni, F et al. (2009). Epilepsy in onchocerciasis endemic areas: systematic review and meta-analysis of population-based surveys. PLoS Negl Trop Dis; 3: e461. .CrossRefGoogle ScholarPubMed
Remme, JHF (2004). The global burden of onchocerciasis in 1990. Geneva: World Health Organization.Google Scholar
Saint André, A, Blackwell, NM, Hall, LR et al. (2002). The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness. Science; 295: 1892–5.CrossRefGoogle ScholarPubMed
Tekle, AH, Elhassan, E, Isiyaku, S et al. (2012). Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control. Parasit Vectors; 5: 28. .CrossRefGoogle ScholarPubMed
Timmann, C, Abraha, RS, Hamelmann, C et al. (2003). Cutaneous pathology in onchocerciasis associated with pronounced systemic T-helper 2-type responses toOnchocerca volvulus. Br J Dermatol; 149: 782–7.CrossRefGoogle ScholarPubMed
World Health Organization (2009). New drug that could dramatically speed up the elimination of river blindness across Africa begins clincial trial.
World Health Organization (2010a). African Programme for Onchocerciasis Control website: . (accessed 2/5/10).
World Health Organization/TDR (2010b). African Programme for onchocerciasis Control – report of the sixth meeting of national task forces, October 2009. Wkly Epid Rec; 22 January 85(4): (pp23–28). .Google Scholar
Yang, YF, Murdoch, IE, Cousens, S et al. (2001). Intraocular pressure and gonioscopic findings in rural communities mesoendemic and nonendemic for onchocerciasis, Kaduna State, Nigeria. Eye; 15: 756–9.CrossRefGoogle ScholarPubMed
Zimmermann, P.A., Guderian, R.H., Aruajo, et al. (1994). Polymerase chain reaction-based diagnosis of Onchocerca volvulus infection: improved detection of patients with onchocerciasis. J Infect Dis; 169: 686–9.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×